Status:
COMPLETED
Home Pulmonary Rehabilitation for COPD
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Emphysema
Eligibility:
All Genders
40-99 years
Phase:
NA
Brief Summary
Regular physical activity has been found to be important in maintaining health and well-being in people with COPD. The purpose of this study is to test new technology and health coaching aimed to help...
Eligibility Criteria
Inclusion
- Clinical diagnosis of COPD, confirmed by spirometry
- Age ≥40 years (to avoid recruiting participants with asthma rather than COPD)
- Current or previous smoker (≥10 packs per year)
- Confidence in using the proposed pulmonary rehabilitation (PR) system
- English language fluency
Exclusion
- Study candidate experiencing an acute COPD exacerbation (can be included after the acute event)
- Inability to walk (orthopedic-neurologic problems or confined to a bed)
- Currently in PR or finished PR in the last three months (unlikely to improve)
- Pregnant women
- Live in an area where cell phones do not work/
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 16 2022
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT03480386
Start Date
January 1 2019
End Date
February 16 2022
Last Update
February 13 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
2
Health Partners
Minneapolis, Minnesota, United States, 55122
3
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905